Renzhi Han

机构：University of Nottingham Ningbo China, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0000-0002-8202-9186

发表论文 137 篇 · 总被引 4840 次 · h-index 35

代表论文

• Recent advances in therapeutic gene-editing technologies (2025 · Molecular Therapy · 被引 43)
• Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice (2024 · Nature Communications · 被引 34)
• Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response (2024 · Cells · 被引 17)
• Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy (2025 · Molecular Therapy · 被引 5)
• Rapidly evolving genome and epigenome editing technologies (2024 · Molecular Therapy · 被引 5)
• IDOL Deficiency Inhibits Cholesterol-Rich Diet–Induced Atherosclerosis in Rabbits (2025 · Arteriosclerosis Thrombosis and Vascular Biology · 被引 3)